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Wernicke Encephalopathy Definition
In 1852, Magnus Huss mentioned a disturbance of 
memory in alcoholics, arguments that have been then elu-
cidated between 1887 and 1891 by the Russian psychia-
trist SS Korsakoff, who considered that the polyneuropa-
thy and the memory disorder represented ‘two facets of 
the same disease’, which was designated psychosis poly-
neuritica.
Carl Wernicke described first Wernicke encephalopa-
thy in 1881. He reported a pathological clinical situation, 
which comprises a triad of symptoms with acute mental 
confusion, ataxia, and ophthalmoplegia. He described 
three patients, two with a story of high alcohol consump-
tion and one patient with persistent vomiting that pre-
sented with progressive stupor and coma, progressing to 
death. After this, the classical triad was then deeply de-
scribed, however, the combination of all three symptoms 
is only observed in one-third of patients with Wernicke 
encephalopathy [1].
 Therefore, actually, we accept the definition given by 
general experience, considering the syndrome as an acute 
neuropsychiatric syndrome, caused by thiamine (vitamin 
B1) deficiency. Often Wernicke encephalopathy is difficult 
to diagnose because its clinical symptoms are nonspecific, 
but delays in treatment can result in coma and death. The 
disease commonly results from chronic alcohol depend-
ency, anyway non-alcoholic causes are reported in 20% to 
50% of patients. Less commonly Wernicke encephalopa-
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thy may be seen in patients with cancer and malignant 
lymphoma due to persistent vomit, protein depletion, use 
of chemotherapeutic agents and malnutrition [2-4].
Other predisposing factors for Wernicke encepha-
lopathy are: a staple diet of polished rice, chronic malnu-
trition, gastrointestinal surgical procedures, chronic diar-
rhoea, systemic disease and magnesium depletion.
Alcohol consumption is at special risk for thiamine 
deficiency because is usually associated with a poor diet 
and malnutrition, moreover in heavy drinker also com-
promised thiamine absorption from the gastrointestinal 
tract, reduced thiamine phosphorylation and impaired 
thiamine storage is common [5]. 
As we already said, sleeve gastrectomy (that is con-
tinuously increasing in prevalence during last decades) 
may be related to malabsorbitive, restrictive or mixed dis-
orders. Moreover after the surgical intervention hormonal 
changes (especially regarding the lipoprotein metabolism 
and glucose metabolism) responsible of thiamine defi-
ciency has been demonstrated, meaning that the effect of 
this procedure is more complex than it seems to be. Be-
side the complications due to the surgical procedure (ste-
nosis of the sleeve gastrectomy, anastomotic leak, bleed-
ing or infection) nutritional deficiency and particurarly 
vitamin B1 deficit has been described. All this can lead 
to Wernicke´s encephalopathy with a 20% mortality rate 
when it is undertreated [2,6,7]. 
Similarly an unbalanced diet may be responsible of a 
thiamine deficiency. In developed countries an increasing 
number of non-alcoholic cases of Wernicke’s encephalop-
athy are reported as a result of an extreme diet with fast-
ing/starvation and use of diet pills. Elsewhere the clini-
cal case of an adult woman following a 40-day water-only 
fasting diet who developed Wernicke’s encephalopathy 
was described [8,9]. 
Majchrzak at al studied the B-vitamin status in Aus-
trian population. They found that Vegans presented a sig-
nificantly lower mean plasma vitamin B(12) concentra-
tion than omnivores and vegetarians. As well as the status 
of riboflavin is considered to be deficient in about 10% 
of omnivores and vegetarians and in over 30% of vegans. 
Concluding that Vitamins B(12) and B(2) may need atten-
tion in the strict vegan diet [10]. 
During hospitalization Wernicke’s encephalopathy 
might occur in patients on prolonged parenteral nutrition 
[11,12].
Clinical Features
The clinical triad described by Wemicke is composed 
of ophthalmoplegia, ataxia and disturbance of conscious-
ness and mental state. 
Ocular abnormalities are the hallmarks of Wernicke 
encephalopathy. The oculomotor signs are nystagmus, bi-
lateral oculomotor palsies, and conjugate gaze palsies have 
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been described. Less frequently pupillary abnormalities, 
ptosis, scotomata, and anisocoria have been reported. 
Encephalopathy is characterized by a global confu-
sional state, disinterest, inattentiveness, or agitation, and 
delirium (nocument, ideative and persecution delusion).  
Gait ataxia is likely to be a combination of pre-ex-
isting polyneuropathy, cerebellar damage, and vestibular 
paresis. Vestibular dysfunction without hearing loss is a 
common finding. In less severe cases, patients walk slowly 
with a broad-based gait. Diencephalic sufferance is quite 
common, due to pre-existing alcoholic polyneuropathy 
and hypothalamus dysfunction.
Hypothermia is common because of the involvement 
of the temperature-regulating center in the brainstem. 
Hypotension, caused by a defect in efferent sympathetic 
outflow and decreased peripheral resistance, due to auto-
nomics failure and secondary to alcoholic liver disorder, 
may be present. 
Not very frequently, patients survive to Wernicke en-
cephalopathy; among the survivors, there is a large per-
centage of Korsakoff complex psychosis, characterized by 
the following: retrograde amnesia (inability to recall in-
formation), anterograde amnesia (inability to assimilate 
new information), decreased spontaneity and initiative, 
and confabulation. Firstly Korsakoff, a Russian psychia-
trist, published different reports describing a syndrome of 
anterograde amnesia—an inability to form new memo-
ries—and confabulation which refers to the practice of 
filling in gaps the memory by fabricating new memories, 
in individuals with severe alcoholism or severe starvation. 
The symptoms of Wernicke’s encephalopathy appear 
suddenly. The most prominent symptom initially is men-
tal confusion including memory problems. On examina-
tion, patients have difficulty moving their eyes to follow 
a visual stimulus mostly due to external recti deficit. The 
sufferance might involve the third, fourth or sixth cranial 
nerves. Moreover, nystagmus that is both horizontal and 
upright, and paralysis of conjugate gaze can be detected. 
Pupillary disturbances, ptosis and even funduscopic ab-
normalities are distinctly rare, thought reported from 
time to time.
Problems maintaining balance while standing or walk-
ing, a condition known as ataxia, are frequently observed 
as well. If left untreated, most of these symptoms may 
resolve spontaneously, but the severe memory disorder 
characteristic of Korsakoff syndrome remains. The typical 
person with Korsakoff syndrome appears fairly normal on 
first impression. Intelligence is intact, and individuals with 
the syndrome can carry on a conversation quite naturally. 
They are usually able to recall and talk about incidents that 
took place before the onset of the disorder and recognize 
family members and old friends without much difficulty. 
The ability to form new memories is nearly absent, how-
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ever. In the course of conversation, people with Korsa-
koff syndrome may repeat comments or questions several 
times. They will fail to recognize people they met minutes 
before or greet a friend with excitement and surprise after 
a brief trip to another room. These are the characteristics 
of anterograde amnesia. Research shows that anterograde 
amnesia results from a failure of memory formation and 
storage. New information is processed normally, but al-
most immediately forgotten, never making it into the re-
gions of the brain where memories of the past are stored. 
People with Korsakoff syndrome thus have no memories 
of events that happened after the onset of the illness. Many 
previously stored memories are still available, explaining 
why individuals with Korsakoff syndrome can usually re-
member the distant past quite well.
Mechanism of Damage
Studies of pyrithiamine-induced thiamine deficiency 
(PTD), an animal model of Wernicke’s encephalopathy, 
have in the past failed to directly relate parameters such 
as thiamine ester depletion [13], thiamine-dependent 
enzyme changes  [14,15], and receptor binding sites [16-
18] to the cause of the selective nature of the histological 
changes that occur in this disorder. Variability between 
different groups of investigators, in the experimental pro-
cedure employed to produce thiamine deficiency over the 
years has led to differences in the type of model produced, 
thus complicating attempts to identify the sequelae of 
events that occur during the evolution of the disorder.
In a landmark series of studies, Victor and colleagues 
reported that examination of the brains of patients diag-
nosed with Wernicke’s encephalopathy typically reveals 
gross neuropathological changes that include an increase 
in the size of the lateral and third ventricles with sub-
ventricular regions of the thalamus showing the pres-
ence of histological lesions [19]. In the majority of cases, 
the mammillary bodies sustained considerable damage. 
Hemorrhagic lesions were present in a small percentage of 
cases, mostly in the form of petechae, and were seen most 
frequently in mammillary bodies as well as the medial, 
midline and intralaminar nuclei of the thalamus, superior 
and inferior colliculi, periaqueductal area and floor of the 
fourth ventricle. Lesions of the cerebellum were reported 
in approximately one third of cases, with damage localized 
to the folia of the vermis. It seems quite difficult to obtain 
adequate information in order to detect previously vermis 
atrophy due to chronic alcohol abuse or thiamine deficit. 
In the thalamus, the most frequently affected region 
was the medial dorsal nucleus which showed damage in 
all cases studied. The hypothalamus showed abnormalities 
in almost all cases with the most prominent lesions in the 
mammillary bodies. In general, those regions of the brain 
in close proximity to the ventricular system displayed the 
most serious histological damage. Loss of neurons was the 
most obvious abnormality in structures such as the thala-
mus and cerebellar vermis, with some involvement of fibre 
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tracts [20]. In addition, brain shrinkage seen in Wernicke’s 
encephalopathy has been attributed to loss of both white 
matter and neurons of the cerebral cortex [20-22]. Areas 
of the brain showing selective vulnerability do not nor-
mally share a common origin in embryologic terms [23], 
and are unrelated in their vascular supply. In affected ar-
eas, swelling of astrocytes is often observed with decreases 
in myelinated fibres and a patchy loss of nerve cells ac-
companied by activated microglia and reactive astroglio-
sis. Alterations in the morphology of glia represent the 
earliest histological changes seen in thiamine deficiency 
[24,25]. Such changes are suggestive of metabolic changes 
in these cells which may have an important role to play in 
the pathophysiology of this disorder.
In a study by Torvik [26], the nature of the neuro-
pathological lesions in patients with Wernicke’s encepha-
lopathy was found to depend on the prominent involve-
ment of the different region of brain. In particular, damage 
to the mammillary bodies and paraventricular structures 
of the brainstem was different to that of the thalamus and 
inferior olives. This study was the first to suggest that two 
different types of structural lesions occurred in this disor-
der, and indicates the likelihood of more than one mecha-
nism of brain cell damage in these patients.
Studies of post mortem brain samples from Wernicke’s 
encephalopathy patients have been limited in number.
In an early study, levels of trace elements were exam-
ined by neutron activation analysis in a small group of 
patients with alcohol abuse exhibiting clinical features of 
Wernicke’s encephalopathy [27]. Decreases in nearly all 
elements studied were found in structures with known 
vulnerability in this disease. Reductions in thiamine-de-
pendent enzymes have been reported in autopsied sam-
ples of cerebellum derived from the brains of patients with 
neuropathological confirmation of PTD [28]. Examina-
tion of GABAA receptor binding sites in the cerebral cor-
tex of alcoholics with neuropathologically confirmed WE 
showed different characteristics compared to control ma-
terial [29]. Altered gene expression of GABAA receptor 
subunit isoforms was proposed as a contributing factor 
[30], although the cause of these differences is unknown. 
Other studies have demonstrated an alteration of endor-
phin/thiamine relationships in the brains of Wernicke pa-
tients [31], suggestive of a dysfunction of the endorphin-
ergic system.
Although there are several comprehensive descrip-
tions of the neuropathology of Wernicke’s encephalopathy 
[19,32,33], definitive anatomical substrates for the associ-
ated amnesic syndrome, Korsakoff ’s psychosis, have not 
been identified. Cullen et al. [34] have previously shown 
that the cholinergic nucleus basalis (Ch4) is an exclusive 
site of neurofibrillary degeneration in thiamine deficient 
alcoholic patients [35]. The degree of Ch4 cell loss in 
tightly associated with the memory disorder Korsakoff ’s 
psychosis. The notion that cholinergic deficits can result 
in memory dysfunction has been extensively evaluated 
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in several animal and pharmacological models as well as 
in neurodegenerative diseases, most notably Alzheimer’s 
disease.
A role for the Ch4 in memory has been supported in 
Korsakoff ’s psychosis correlating loss of magnocellular 
basal forebrain neurons to memory dysfunction [36,37].
Cullen et al. [34] demonstrated that in the vicinity 
of the Ch4, gross morphological changes including fore-
brain atrophy, ventricular dilatation, and glial scarring 
disrupted the normal forebrain architecture and gave an 
irregular concave appearance to the base of the brain in 
all cases of Wernicke’s encephalopathy. In these cases, 
the Ch4 nucleus appeared as a narrower, denser band of 
cells along the basal surface of the brain compared with 
alcoholic patients without Wernicke’s encephalopathy and 
controls. Accumulation of lipofuscin pigment was pro-
nounced in all alcoholic patients. Comparison of cell size 
of Ch4 neurons disclosed no significant difference in the 
mean cell diameters between Korsakoff ’s psychosis, Wer-
nicke’s encephalopathy, alcoholic, and non-alcoholic con-
trol groups, even if mean cells diameters could be below 
in the control group.
There was no significant difference in cell number be-
tween alcoholic controls and non-alcoholic age matched 
controls. The mean number of Ch4 neurons in the Kor-
sakoff ’s psychosis and Wernicke’s encephalopathy groups 
differed significantly from non-alcoholic control groups, 
with the Wernicke’s encephalopathy mean 24% and the 
Korsakoff ’s psychosis mean 21% below that of controls. 
These results corroborate earlier reports that cell number 
remains unchanged in alcoholic patients without Wer-
nicke’s encephalopathy [38]. The data also show that Ch4 
cell number is reduced in patients with Wernicke’s en-
cephalopathy both with and without Korsakoff ’s psycho-
sis, consistent with our previous finding of neurofibrillary 
tangles in the Ch4 of alcoholic patients with Wernicke’s 
encephalopathy [35].
Evidence of cell loss in non-amnesic patients with 
Wernicke’s encephalopathy, however, refutes previous, as 
yet unchallenged, conclusions of a causal relation between 
reduced Ch4 cell number and memory loss [37]. These 
results cast doubt on the notion that alcoholic Korsakoff ’s 
psychosis is a “basal forebrain” amnesia [39]. Although 
Ch4 cell loss cannot account for the amnesia of Korsa-
koff ’s psychosis, lower Ch4 cell number may contribute 
to cognitive dysfunction in patients with Wernicke’s en-
cephalopathy, both with and without Korsakoff ’s psycho-
sis [33,40].
Biochemical Aspects
Thiamine is a water soluble heat labile quaternary am-
monia compound, containing an aminopyrimidine ring 
linked by a methylene bridge to a thiazole ring [41]. It is 
synthesized by different biochemical reactions in fungi, 
bacteria, plants and some protozoa, but not in humans 
[42]. 
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In the human body it is found as unphosporilated 
thiamine (i.e. free TH) and as phosphorilated derivates: 
thiamine monophospate (THMP), thiamine diphospate 
(THDP, aka TH pyrophosphate), and thiamine triphospate 
(THTP). Intracellularly, free thiamine is converted by thi-
aminpyrophosphokinase into THDP, in a process requir-
ing Magnesium as cofactor. Three plasma membrane bidi-
rectional transporters for thiamine and thiamine derivates 
have been described: TH transporter 1 (THTR1) encoded 
by the SCL19A2 gene (location 1q23.3), TH transporter 2 
(THTR2) encoded by the SCL19A3 gene (location 2q37) 
and reduced folate carrier transporter 1 (RFC1) encoded 
by the SCL19A1 gene (location 21q22.3). A mitochon-
dria membrane transporter for THDP (i.e. mitochondria 
membrane THDP transporter) encoded by the SCL25A19 
has also been described. THTR1 and THTR2 transport 
free TH. THTR1 seems to be highly expressed in skeletal 
and heart muscle and to lesser degrees in placenta, liver, 
kidneys, small intestine and lungs. THTR2 seems to be 
highly express in the placenta, kidneys, liver and thalamus 
and also in the small intestine. RFC1 is mainly a folate 
transporter, but also transports THDP and THMP. Con-
sidering that THDP is found exclusively intracellularly, 
RFC1 transports THDP only from the intracellular to 
the extracellular space (where THDP is rapidly converted 
to free TH). In the presence of low free TH and THMP 
plasma levels the cells that highly express RFC1 on their 
membranes have an overall negative TH balance, export-
ing THDP without importing free TH or THMP. RFC1 is 
highly expressed on the apical brush border of the cho-
roid plexus. The intestinal absorption of thiamine occurs 
mainly in the proximal small intestine by an active stor-
able mechanism and probably also by passive diffusion. 
At the intestinal brush border thiamine is mainly 
found in its free form. thiamine absorption is enhanced 
by thiamine deficiency and reduced by thyroid hor-
mones, ethanol exposure, low temperature and thiamine 
analogues. Thiamine absorption may also be reduced in 
those with diabetes mellitus or advanced aged. At low 
concentration (<2 microM/liter) thiamine absorption is 
an active, rate-limited process, involving the high affinity 
THTR2 and, to a lesser extent, THTR1. At high intesti-
nal thiamine concentration (5-50 microM/liter) thiamine 
seems to be absorbed through passive diffusion.  
Thiamine has restricted distribution. Up to 90% of 
the circulating thiamine is found in the red cells (mostly 
as THDP), the rest being found in the other blood cells 
and in plasma, mainly bound by proteins, as free TH or 
THMP [43,44]. 
Under physiologic circumstances, thiamine is excret-
ed through kidney. 
The blood brain barrier (BBB) allows the passage of 
free thiamine and THMP through both active and pas-
sive mechanisms. Active passage occurs at low thiamine 
serum concentrations. At high serum concentrations, free 
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thiamine passes the BBB passively, driven by the existing 
concentration gradient. 
Thiamine may have a structural role as part of the 
cellular membranes, and may be involved in the synaptic 
transmission, cellular differentiation, axonal growth, my-
elinogenesis and regulation of brain development during 
foetal and early postnatal life. To the best of our knowl-
edge THMP and THTP have no clearly identified meta-
bolic or structural roles [45].  THDP serves as a cofac-
tor for several apoenzymes involved in the carbohydrate 
metabolism: apo-alpha-ketoglutarate dehydrogenase 
(aKGDH), apo-pyruvate dehydrogenase (PDH) and apo-
transketolase (TK). Mg is the second cofactor required 
by these apoenzymes, especially by apo-TK. aKGDH and 
PDH are mitochondrial enzymes important for the tricar-
boxylic acid cycle (TAC, i.e. Krebs cycle), though the lat-
ter is not part of it. TK is a cytosolic enzyme involved in 
the nonoxidative phase of the pentose-phosphate pathway 
(PPP or hexose monophosphat shunt) [43]. 
It has been shown that TH deficiency inhibits the 
expression of the genes encoding TK and PDH [46,47]. 
Under physiologic circumstances, almost 30% of the brain 
glucose is metabolized to pyruvate. In the absence of a 
functional PDH complex and Krebs cycle pyruvate is re-
duced to lactate [48]. 
The human body has thiamine deposits ranging from 
25 to 50 mg, commonly corresponding to the amount of 
thiamine required for 18 to 42 days. Most of the thiamine 
is stored in the liver as THDP. Food sources of thiamine 
are cereals, beans, nuts, brown (unpolished) rice and 
meat. Polished (white) rice, highly purified cereals and ex-
cessively cooked food may contain no thiamine. The daily 
thiamine requirements for a healthy adult may range from 
1 to 2 mg and depend on the carbohydrate intake and on 
several metabolic factors. According to the current litera-
ture, the thiamine intake should be of at least 0.33 mg per 
1000 kcal, ideally 0.5 mg per 1000 kcal, but no less than 1 
mg per day. 
Thiamine deficiency is the predisposing factor most 
frequently associated with Wernicke Encephalopathy. 
Thiamine deficiency is the consequence of one or 
more of the following mechanisms: inadequate dietary in-
take (absolute or relative), impaired intestinal absorption, 
impaired storage, excessive elimination and/or increased 
metabolic requirements. Impaired thiamine intestinal 
absorption may occur due to gastrointestinal diseases, 
protein-caloric malnutrition (decrease in the active TH 
absorption) and/or ingestion of certain substances (e.g. 
‘anti-TH factors’, antacids, phenytoin, cephalosporins, 
tetracycline). Impaired thiamine storage may occur also 
in chronic liver disease. Moreover, excessive renal elimi-
nation may occur due to renal disease, use of certain 
drugs and/or impaired thiamine storage. In those already 
marginally deficient Wernicke Encephalopathy may be 
precipitated by an event that rapidly increases the meta-
bolic requirements of thiamine [19]. In most of the cases, 
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thiamine deficiency may be traced back to improper diet. 
Regardless of the cause, unbalanced nutrition persisting 
for more than 14 to 21 days, or even less in those already 
marginally deficient or with higher demands, may lead to 
thiamine deficiency. In healthy adults, intakes of less than 
0.2 mg per 1000 kcal or of less than 0.66 mg per day last-
ing for several weeks lead to clinically manifest thiamine 
deficiency. 
Gender may influence the risk of developing Wernicke 
Encephalopathy, possibly because of genetic differences 
but also because of gender-related environmental factors. 
No definite race predisposition has been described, but 
a population-specific susceptibility has been reported: it 
seems that Asians with thiamine deficiency are prone to 
cardiovascular beriberi, while Europeans with thiamine 
deficiency are more likely develop neurological beriberi 
and/or Wernicke Encephalopathy [2].
Chronic ethanol abuse is the condition most fre-
quently associated to Wernicke Encephalopathy. Alcohol-
ics may have higher thiamine demands, thiamine being 
necessary for the metabolism of ethanol. They frequently 
have thiamine intake below 0.29 mg per 1000 kcal and as-
sociate Mg depletion [5]. They may have impaired thia-
mine absorption secondary to ethanol-induced intestinal 
mucosa damage, impaired transmembrane transport due 
to folate or other B vitamins deficiency, decreased in-
testinal ATP-ase activity and reduced expression of the 
THTR1 and THTR2 encoding genes [49,50].
In the late 1970s, a biochemical study showed that, in 
fibroblasts from patients with Wernicke-Korsakoff syn-
drome (WKS), transketolase had decreased affinity for 
thiamine pyrophosphate [51]. The abnormality persisted 
through several generations of culture medium in the 
presence of excess thiamine and absence of ethanol. Thus, 
the occurrence of this enzyme variant may put individuals 
at risk for Wernicke’s encephalopathy when on a diet mar-
ginal or deficient in thiamine. This finding is consistent 
with other studies in isolated populations and in monozy-
gotic twins concordant for WKS.
Although there were some variants in the nucleotide 
sequence of the transketolase coding region in fibroblasts 
derived from patients with WKS, there were no aminoacid 
sequence variations [43] or RNA splicing variants. Other 
mechanisms, such as post-translational modifications or 
different assembly of proteins, have been postulated to 
explain the difference in biochemical activity of transke-
tolase in WKS.  Furthermore, variation in the X-linked 
transketolase-like 1 (TKTL1) gene might also contribute 
to genetic susceptibility to WKS [52]. Other findings pro-
vide evidence for a role of the GABA-A receptor subunit 
gene cluster on chromosome 5q33 in susceptibility both 
to the alcohol-dependence syndrome and Korsakoff ’s syn-
drome [53]. More recently, another gene coding for the 
high-affinity thiamine transporter protein SLC19A2 has 
been implicated in the pathophysiology of WKS [54,55]. 
Mutation screening identified three new genetic vari-
ants in the 3Ľ untranslated region of the high-affinity thia-
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mine transporter in 25 people with alcoholism and WKS 
[55]. The 3Ľ untranslated region is important in terms of 
gene regulation and protein expression [56]. Subtle ge-
netic changes in the effectiveness of the various transport 
systems of thiamine in patients who develop Wernicke’s 
encephalopathy might ultimately lead to diminished abil-
ity to transport thiamine into brain cells.  This functional 
impairment could contribute to an individual’s ability to 
cope with thiamine deficiency or respond to therapy [57].
Moreover, some gene polymorphisms, although not 
directly involved in the pathogenesis of WKS, might have 
a modifying role in the severity of clinical phenotype. One 
of the best characterised is the APOE ε4 allele, a well-
known risk factor for Alzheimer’s disease. In patients with 
WKS and global intellectual deficiency, the frequency of 
the ε4 allele is significantly higher than in patients with 
WKS and preserved intellectual function other than am-
nesia, suggesting the involvement of this allele in the intel-
lectual decline of patients [58]. 
In WKS several genetic defects might combine with 
environmental factors to generate the phenotype, and 
these genetic defects become clinically important when 
the diet is deficient in thiamine. 
Thiamine deficiency leads to brain lesions—usually 
restricted to selective, vulnerable regions, with high thia-
mine content and turnover—within 2–3 weeks [59].  This 
timescale is related to the time necessary to deplete the 
body’s stores of thiamine, which are only sufficient for up 
to 18 days. After about 3 weeks of thiamine deficiency, 
the blood levels of thiamine also fall, leading to impaired 
function of enzymes requiring thiamine pyrophosphate as 
a coenzyme [59]. 
Thiamine in its metabolically active form, called thia-
mine pyrophosphate (TPP), is vital in the metabolism of 
carbohydrates. It serves a critical role in 3 enzyme systems: 
conversion of pyruvate to acetyl coenzyme A by pyruvate 
dehydrogenase, conversion of alpha-ketoglutarate to suc-
cinate by alpha-ketoglutarate dehydrogenase in the Krebs 
cycle catalysis by transketolase in the pentose monophos-
phate shunt [20]. 
In the presence of thiamine deficiency, these cellular 
systems dependent on thiamine begin to fail, leading even-
tually to cell death. Diminished transketolase activity re-
sults in failure of the maintenance of the myelin sheaths in 
the nervous system, metabolism of lipids and glucose, and 
production of branched chain amino acids. Lack of alpha-
ketoglutarate dehydrogenase activity in the Krebs cycle al-
ters cerebral energy utilization. If cells with high metabolic 
requirements have inadequate stores of thiamine to draw 
from, energy production drops, and neuronal damage en-
sues. Increased cell death feeds the localized vasogenic re-
sponse. The alpha-ketoglutarate dehydrogenase complex 
(KGDHC) activity is considerably decreased in several 
brain regions that ultimately develop histological dam-
age in Wernicke Encephalopathy [14,15,60] including the 
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thalamus. The earliest biochemical change is the decrease 
in α-ketoglutarate-dehydrogenase activity in astrocytes, 
which occurs after about 4 days of thiamine deficiency 
[60]. This is consistent with findings from animals with ex-
perimental thiamine deficiency, which consistently show 
early damage to glial cells rather than neurons [25,61]and 
patients with WKS, who have changes in astroglia togeth-
er with microglial proliferation apparent even in regions 
of the brain with little if any neuronal cell death.  A reduc-
tion in the activity of transketolase is noticed after about 
1 week of thiamine deficiency, whereas no change in the 
activity of pyruvate dehydrogenase is observed for up to 
10 days [60].  This metabolic impairment produces a dif-
fuse decrease in the use of glucose in the brain, with con-
sequent severe impairment of cellular energy metabolism 
[62].  In particular, many astrocyte related functions are 
impaired, such as the control of intracellular and extracel-
lular glutamate concentrations (with probable occurrence 
of glutamate-mediated excitotoxicity), the maintenance 
of ionic gradients across the cell membrane, and blood–
brain barrier permeability [20]. Moreover, in Wernicke’s 
encephalopathy at the symptomatic stage, increased lac-
tate production by both neurons and astrocytes has been 
noticed, with intracellular accumulation of lactate, reduc-
tions in pH, and focal acidosis [63]. DNA fragmentation 
in thalamic neurons resulting in apoptotic cell death ap-
pears after about 2 weeks of thiamine deficiency [64]. 
Other mechanisms involved include mitochondrial 
dysfunction and intracellular oxidative stress with pro-
duction of free radicals and cytokines as a result of early 
endothelial-cell dysfunction and increased production of 
nitric oxide [65].  The main consequence of these meta-
bolic changes is the loss of osmotic gradients across cell 
membranes, with cytotoxic oedema and a progressive cell-
volume increase firstly in astrocytes, then in neurons [66]. 
Decreased α-ketoglutarate-dehydrogenase activity result-
ing from thiamine deficiency, changes in the synthesis of 
aminoacids, and the accumulation of lactate in the brain 
are initially reversible after prompt and sufficient thia-
mine therapy the so called stage of “reversible biochemi-
cal lesion” [66]. Conversely, a lack or delay of thiamine 
rehabilitation may lead to structural, irreversible lesions 
in selective regions of the brain with possible permanent 
neurological sequelae or a fatal outcome [19].
The loss of KGDHC activity is associated with revers-
ible decreases in concentrations of the neuroactive amino 
acids glutamate, aspartate, and GABA, suggesting that 
these amino acids play a significant role in the develop-
ment of this biochemical lesion. However, recovery of 
KGDHC activity and levels of GABA and aspartate fol-
lowing thiamine replenishment are incomplete, which 
may be indicative of permanent structural damage in this 
region. Additionally, the reduced production of succinate, 
which plays a role in GABA metabolism and the electri-
cal stimulation of neurons, leads to further CNS injury. 
Increased lactic acid production ensues in the absence of 
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pyruvate dehydrogenase function, as the reduced conver-
sion of pyruvate to acetyl coenzyme A results in less ef-
ficient oxidative phosphorylation.
Furthermore, the time course of onset of neurological 
symptoms of thiamine deficiency has been correlated with 
the fall in brain transketolase activity [67,68]. This enzyme 
is involved in the pentose phosphate shunt, an important 
pathway that supplies both ribose sugar residues neces-
sary for nucleic acid synthesis as well as fatty acids for 
maintenance of membrane phospholipid integrity. In a 
recent study, it was revealed that decreased stability of the 
transketolase protein or a reduction in mRNA translation 
of the enzyme due to thiamine deficiency is the major fac-
tor responsible for the lowered activity [69]. Various stud-
ies provide evidence for an involvement of glutamate as 
an underlying mediator of CNS dysfunction and damage 
in PTD. Brain glutamate levels are reduced in whole brain 
of PTD animals as well as in vulnerable regions such as 
the pons and thalamus [14]. These findings are consist-
ent with earlier reports of a decrease in the conversion 
of [14C] glucose to glutamate in symptomatic PTD rats 
[70,71] and reduced Ca2+ dependent release of glutamate 
in hippocampal slices from symptomatic animals [20]. 
Armstrong-James and co-workers [72] reported a similar-
ity in the appearance and development of the central tha-
lamic lesion in thiamine deficiency to that observed fol-
lowing intrathalamic administration of excitatory amino 
acids. Additionally, the extent of cell death can be reduced 
in brain regions affected in thiamine deficiency following 
treatment with the non-competitive NMDA receptor an-
tagonist MK-801 [73,74]. Also consistent with glutamate 
excitotoxic mechanisms are the findings that extracellular 
glutamate concentrations are increased in the posterior 
thalamus during induction of Wernicke’s encephalopathy 
[75]. It has been reported that the thalamus undergoes a 
process of apoptotic cell death in PTD rats [64]. Further-
more, a study of immediate-early genes (IEGs) revealed 
for the first time that the expression of c-fos, c-jun,fos-B 
and NGFI-A is dramatically increased in, and localized to, 
vulnerable regions of the brain such as the medial thala-
mus and inferior colliculi at the symptomatic stage of PTD 
in advance of the appearance of necrotic lesions [20]. An 
earlier increase in c-fos expression was also described in 
the same report, consistent with the initiation of a pre-
symptomatic apoptotic event. IEGs encode transcription-
al regulating factors that are induced following depolari-
zation [76], a process also observed during PTD [20], and 
these factors are implicated in the control of genes which 
mediate both apoptosis and excitotoxic-induced cell death 
[77].
Diagnosis
Wernicke Encephalopathy is essentially a clinical di-
agnosis. The differential diagnosis should include several 
diseases like stroke and intracranial haemorrhage, men-
ingitis and encephalitis, brain tumors, cerebellar diseases, 
toxic ingestions, liver failure, Marchiafava-Bignami dis-
ease, and metronidazole-induced encephalopathy. 
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Galvin et al in 2010 published a practical guidelines 
for diagnosis, management and prevention of the disease. 
Following their recommendation the clinical diagnosis of 
Wernicke Encephalopathy in alcoholics requires two of 
this four signs; dietary deficiencies, eye signs, cerebellar 
dysfunction, and either an altered mental state or mild 
memory impairment (Level B). The same recommenda-
tion might be applied also to non-alcoholic patients (GPP) 
[78]. 
Anyway other different biological tests and radiologi-
cal examination may help in the diagnosis. Data from lit-
erature show that for the correct diagnosis the determina-
tion of thiamine blood concentration and red blood cell 
transketolase activity is recommended [79,67].
The erythrocyte transketolase activity assay including 
thiamine pyrophosphate effect has been replaced by di-
rect measurement of thiamine and its phosphate esters in 
human blood by high-performance liquid chromatogra-
phy (HPLC) [80,81]. Thiamine assay is available in many 
countries. Adult normal range (60–220 nM) and the low-
est detectable level (3–35 nM) are given, however, normal 
thiamine levels do not necessarily exclude Wernicke En-
cephalopathy.
Radiological examinations and especially magnetic 
resonance are mandatory. The most frequently affected re-
gions are the medial thalamus and periventricular region 
of the third ventricle (80%), followed by periaqueductal 
area (59%) and mammillary bodies (45%) [82,83].
Computed tomography (CT) can show areas of re-
duced attenuation density in the periaqueductal grey mat-
ter and in the medial portion of the thalami but, in most 
cases, can be totally negative in the acute phase of the dis-
ease [84]. 
MR might be more specificity and represent an im-
portant tool to get the right diagnosis [85]. Cytotoxic ede-
ma is usually shown on MR images, other typical findings 
may include alterations in the thalami, mamillary bodies, 
tectal plate, and periaqueductal area. Moreover in patients 
with Wernicke Encephalopathy due to alcoholism, other 
common finding include atrophy of the mamillary bodies, 
infratentorial regions, supratentorial cortex, and corpus 
callosum.
Usually in Wernicke Encephalopathy patients the 
cerebral alteration described on neuroimaging examina-
tion, are typically bilateral and symmetrical, with T2w 
and FLAIR (Fluid Attenuation Inversion Recovery) hy-
perintensities in the thalami, mammillary bodies, tectal 
plate, and periaqueductal area.  Cerebellar signal intensity 
alterations can be observed in Wernicke Encephalopa-
thy (both due to alcohol abuse or not), moreover autopsy 
studies have demonstrated that the anterior-superior ver-
mis or anterior hemisphere is affected in more than half 
of patients with Wernicke Encephalopathy. The involve-
ment of the caudate nuclei, in particular of the capita, may 
be due to their adjacent position to the lateral ventricles. 
Moreover, the presence of lesions of the caudate nuclei, 
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frequently observed in patients in comatose state, is a sign 
of pathologic evolution. Data from literature show that 
also cortical involvement brings to an irreversible damage 
and poor prognosis [86,87].
Sometimes TC and MRI scan may be negative, this 
however, does not exclude the diagnosis of Wernicke En-
cephalopathy. In alcoholist patients atrophy of the mam-
millary bodies and the cerebellar vermis are common 
(signs that are not found in non alcoholist ones) [88]. 
For the diagnoses of Wernicke Encephalopathy the 
contribution of CSF examination is still unclear. Very high 
CSF tau levels without increased p-tau have been found. 
It’s known that CSF tau has been proposed as a general 
marker for neuronal degeneration (CSF tau/p tau is in-
creased in Alzheimer’s disease and other dementia syn-
dromes), moreover the level of increase in CSF tau is 
highest in disorders with the most extensive neuronal de-
generation, such as CJD (CSF tau levels and normal p-tau 
levels).
Autopsy series identifying typical brainstem lesions 
of Wernicke Encephalopathy have placed the incidence 
between 0.8% and 2.8% of the general population. How-
ever, the incidence can be as high as 12.5% in a popula-
tion of alcoholics. It has been described in many other 
situations where nutrition has been compromised. These 
cases include patients with AIDS, individuals receiving 
hemodialysis, hyperemesis gravidarum, and malignancy 
with or without chemotherapy. Although it may not be di-
agnosed as frequently in third and fourth world nations, 
the incidence is probably higher in areas where there is 
more malnutrition and less vitamin supplementation. 
Studies suggest that up to 80% of patients with Wernicke 
encephalopathy may not be diagnosed, which makes esti-
mates of mortality unreliable. Wernicke encephalopathy 
is a significantly disabling and potentially lethal condition 
that can be prevented or reversed if treated early. Estab-
lished Wernicke encephalopathy can have major long-
term consequences among patients requiring permanent 
institutional care. It is most often seen in alcoholics, but it 
can be seen in disorders associated with malnutrition and 
also in patients on long-term hemodialysis or with AIDS. 
The disease is frequently unrecognized and is likely more 
prevalent than commonly supposed [89,90].
Treatment
If Wernicke encephalopathy is suspected, prompt 
treatment with parenteral thiamine should be admin-
istered until there is no further improvement in signs 
and symptoms. Prophylactic thiamine supplementation 
should be considered in patients with alcoholism and mal-
nutrition Treatment include dietary supplements and thi-
amine [78]. Actually there is no consensus on the optimal 
dose of thiamine, according to literature data, treatment 
with either 100 or 200 mg thiamine given intravenously 
or intramuscular has been showed to be useful in non-
alcoholics. This treatment has not always been curative in 
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alcoholics, probably because alcoholic patients with Wer-
nicke encephalopathy may need higher doses and 500 mg 
three times daily has been recommended [2]. 
The administration of thiamine has been shown to be 
safe, and treatment should be started as soon as possible. 
Usually the unwanted side-effects to B vitamins are most 
commonly seen after multiple administrations, and most-
ly after intramuscular high dosage administration. It’s not 
clear if otherwise the supplementation of thiamine to food 
may prevent the development of Wernicke encephalopa-
thy (GPP). The prophylactic parenteral administration of 
thiamine might be recommended only after bariatric sur-
gery.
Therefore is still unclear the benefit of thiamine ad-
ministration on cognitive impairment in Wernicke-Kor-
sakoff syndrome. Noradrenaline, serotonin, glutamate 
and acetylcholine have been proposed in the pathogeny of 
the syndrome, but clear recommendation are still lacking. 
Other therapeutically non pharmacologically approach 
have been reported, new data show that the cognitive def-
icits relating to Korsakoff ’s syndrome and non-amnesic 
alcoholism could be improved through cognitive rehabili-
tation [91,92]. Rehabilitation of memory has been mostly 
investigated. The use of elaborative processing, including 
extra processing time, explicit encouragement to generate 
associations and extra retrieval time to improve memory 
has been proposed in different trials. Elsewhere the use 
of self-generation and enactment of concepts to improve 
memory has been reported. Other data regard the im-
provement on executive functioning in Korsakoff ’s syn-
drome.
Conclusions
Consideration for Wernicke encephalopathy should 
be given to patients with any evidence of long-term alco-
hol abuse or malnutrition and any of the following: acute 
confusion, decreased conscious level, ataxia, ophthalmo-
plegia, memory disturbance, hypothermia with hypoten-
sion, and delirium tremens. Wernicke encephalopathy 
should be considered when any patient with long-term 
malnutrition presents with confusion or altered metal sta-
tus. Significant overlap exists between Wernicke enceph-
alopathy and Korsakoff psychosis, in which patients ex-
perience delayed and potentially irreversible anterograde 
and retrograde amnesia. For this reason, the two entities 
have been described together as Wernicke-Korsakoff syn-
drome. Bariatric surgery, human immunodeficiency virus, 
hyperemesis gravidarum, and other disorders associated 
with grossly impaired nutritional status have been asso-
ciated with Wernicke-Korsakoff syndrome. Additionally, 
infantile thiamine deficiency with manifestations of Wer-
nicke syndrome has been reported in infants fed formula 
that was deficient in thiamine.
Implementation therapy, with thiamine is a fun-
damental approach for the treatment of WE: it must be 
avoided the administration of ev glucose, which may 
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cause a precipitation of thiamine defects. No therapy has 
been validated for the treatment of Korsakoff amnestic 
syndrome. Therefore, the clinicians should avoid any po-
tential precipitating factor in specific patients, more at risk 
to develop Wernicke-Korsakoff syndrome.
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